Non-pharmacological Treatment

  • Cornelia BalaEmail author
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


Optimal blood pressure control is associated with an average 50% decrease in incident HF and thus underlying the importance of BP-lowering strategies to prevent HF. Non-pharmacological interventions are recognized as the cornerstone of hypertension prevention and an important adjunctive strategy in individuals already diagnosed with hypertension. Numerous interventions were tested for the efficacy on BP control, but very limited data is yet available to confirm a benefit on the clinical course of hypertension and related complications including risk of heart failure. In the light of current evidence, DASH (Dietary Approaches to Stop Hypertension) pattern, sodium reduction, and physical activity seem to provide the most significant benefits for reduction of heart failure. Other interventions with good level of evidence for lowering BP and recommended by clinical guidelines are weight loss in patients who are overweight or obese, potassium supplementation, and moderation of alcohol consumption.


Non-pharmacological interventions Dietary patterns Sodium reduction Physical activity Weight loss 


  1. 1.
    Levy D. The progression from hypertension to congestive heart failure. JAMA J Am Med Assoc. 1996;275:1557–62. Scholar
  2. 2.
    Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham heart study. Circulation. 2002;106:3068–72. Scholar
  3. 3.
    Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27:1214–8. Scholar
  4. 4.
    Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219. Scholar
  5. 5.
    Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71:e127–248. Scholar
  6. 6.
    Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure. Hypertension. 2001;37:187–93.CrossRefGoogle Scholar
  7. 7.
    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67:968–77. Scholar
  8. 8.
    Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128:81–8. Scholar
  9. 9.
    Okosun IS, Prewitt TE, Cooper RS. Abdominal obesity in the United States: prevalence and attributable risk of hypertension. J Hum Hypertens. 1999;13:425–30.CrossRefGoogle Scholar
  10. 10.
    Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84. Scholar
  11. 11.
    Semlitsch T, Jeitler K, Berghold A, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. 2016;(3):CD008274.
  12. 12.
    Kostis JB, Wilson AC, Shindler DM, et al. Persistence of normotension after discontinuation of lifestyle intervention in the trial of TONE. Am J Hypertens. 2002;15:732–4. Scholar
  13. 13.
    Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for comprehensive medical care of patients with obesity—executive summary. Endocr Pract. 2016;22(Suppl 3):1–203. Scholar
  14. 14.
    Yumuk V, Tsigos C, Fried M, et al. EASO OMTF European guidelines for obesity management in adults. Obes Facts. 2015;8:402–24. Scholar
  15. 15.
    Jordan J, Yumuk V, Schlaich M, et al. Joint statement of the European Association for the Study of obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens. 2012;30:1047–55. Scholar
  16. 16.
    Siebenhofer A, Jeitler K, Horvath K, et al. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev. 2016;(3):CD007654.
  17. 17.
    Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;(8):CD003641.
  18. 18.
    Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132–42. Scholar
  19. 19.
    Bozkurt B, Aguilar D, Deswal A, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134:e535–78.PubMedGoogle Scholar
  20. 20.
    U.S. Department of Health and Human Services and U.S. Department of Agriculture, U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020. Dietary guidelines for Americans, 2015–2020. 8th ed. 2015.
  21. 21.
    Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–24. Scholar
  22. 22.
    Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344:3–10. Scholar
  23. 23.
    Willett WC, Sacks F, Trichopoulou A, et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995;61:1402S–6S.CrossRefGoogle Scholar
  24. 24.
    Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90. Scholar
  25. 25.
    Toledo E, Hu FB, Estruch R, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med. 2013;11:207. Scholar
  26. 26.
    Brader L, Uusitupa M, Dragsted LO, Hermansen K. Effects of an isocaloric healthy Nordic diet on ambulatory blood pressure in metabolic syndrome: a randomized SYSDIET sub-study. Eur J Clin Nutr. 2014;68:57–63. Scholar
  27. 27.
    Ndanuko RN, Tapsell LC, Charlton KE, et al. Dietary patterns and blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2016;7:76–89. Scholar
  28. 28.
    Yokoyama Y, Nishimura K, Barnard ND, et al. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med. 2014;174:577–87. Scholar
  29. 29.
    Levitan EB, Wolk A, Mittleman MA. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med. 2009;169:851. Scholar
  30. 30.
    Levitan EB, Wolk A, Mittleman MA. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol. 2009;104:1416–20. Scholar
  31. 31.
    Fitõ M, Estruch R, Salas-Salvadõ J, et al. Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial. Eur J Heart Fail. 2014;16:543–50. Scholar
  32. 32.
    Papadaki A, Martínez-González MÁ, Alonso-Gómez A, et al. Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail. 2017;19:1179–85. Scholar
  33. 33.
    de Lorgeril M, Salen P, Martin J-L, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation. 1999;99:779–85.CrossRefGoogle Scholar
  34. 34.
    Crowe FL, Appleby PN, Travis RC, Key TJ. Risk of hospitalization or death from ischemic heart disease among British vegetarians and nonvegetarians: results from the EPIC-Oxford cohort study. Am J Clin Nutr. 2013;97:597–603. Scholar
  35. 35.
    Roswall N, Sandin S, Scragg R, et al. No association between adherence to the healthy Nordic food index and cardiovascular disease amongst Swedish women: a cohort study. J Intern Med. 2015;278:531–41. Scholar
  36. 36.
    Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34. Scholar
  37. 37.
    Aburto N, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326. Scholar
  38. 38.
    Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14–26. Scholar
  39. 39.
    Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33:557–76. Scholar
  40. 40.
    Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation. 2013;63:2960–84.Google Scholar
  41. 41.
    Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (cochrane review). Am J Hypertens. 2012;25:1–15.CrossRefGoogle Scholar
  42. 42.
    Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839–46. Scholar
  43. 43.
    Espeland MA, Whelton PK, Kostis JB, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of nonpharmacologic interventions in the elderly. Arch Fam Med. 2010;8:228–36.CrossRefGoogle Scholar
  44. 44.
    Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:475–81. Scholar
  45. 45.
    Elijovich F, Weinberger MH, Anderson CAM, et al. Salt sensitivity of blood pressure. Hypertension. 2016;68:e7–e46.CrossRefGoogle Scholar
  46. 46.
    Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. Br Med J. 2009;339:b4567. Scholar
  47. 47.
    Mente A, O’Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2017;388:465–75. Scholar
  48. 48.
    Del Gobbo LC, Kalantarian S, Imamura F, et al. Contribution of major lifestyle risk factors for incident heart failure in older adults. The cardiovascular health study. JACC Heart Fail. 2015;3:520–8. Scholar
  49. 49.
    Jousilahti P, Harald K, Jula A, Laatikainen T. Salt intake and the risk of heart failure. Eur Heart J. 2017;38:240.CrossRefGoogle Scholar
  50. 50.
    WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization; 2013. p. 102. ISBN 978-92-4-1506236.Google Scholar
  51. 51.
    Powles J, Fahimi S, Micha R, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733. Scholar
  52. 52.
    Harnack LJ, Cogswell ME, Shikany JM, et al. Sources of sodium in US adults from 3 geographic regions. Circulation. 2017;135:1775–83.CrossRefGoogle Scholar
  53. 53.
    Meneton P, Lafay L, Tard A, et al. Dietary sources and correlates of sodium and potassium intakes in the French general population. Eur J Clin Nutr. 2009;63:1169.CrossRefGoogle Scholar
  54. 54.
    World Health Organization. The SHAKE technical package for salt reduction. Geneva: WHO; 2016.Google Scholar
  55. 55.
    Johnson C, Santos JA, McKenzie B, et al. The science of salt: a regularly updated systematic review of the implementation of salt reduction interventions (September 2016–February 2017). J Clin Hypertens. 2017;19:928–38. Scholar
  56. 56.
    Cobb LK, Appel LJ, Anderson CAM. Strategies to reduce dietary sodium intake. Curr Treat Options Cardiovasc Med. 2012;14:425–34.CrossRefGoogle Scholar
  57. 57.
    Mancia G, Oparil S, Whelton PK, et al. The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. Eur Heart J. 2017;38:712–9.PubMedGoogle Scholar
  58. 58.
    Trieu K, Neal B, Hawkes C, et al. Salt reduction initiatives around the world—a systematic review of progress towards the global target. PLoS One. 2015;10:e0130247. Scholar
  59. 59.
    Zhang Z, Cogswell ME, Gillespie C, et al. Association between usual sodium and potassium intake and blood pressure and hypertension among U.S. adults: NHANES 2005–2010. PLoS One. 2013;8:e75289. Scholar
  60. 60.
    Mente A, O’Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11. Scholar
  61. 61.
    Kieneker LM, Gansevoort RT, Mukamal KJ, et al. Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2014;64:769–76. Scholar
  62. 62.
    Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356:1966–78. Scholar
  63. 63.
    Stamler J. The INTERSALT study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65:626S–42S. Scholar
  64. 64.
    Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624–32. Scholar
  65. 65.
    Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003;17:471–80. Scholar
  66. 66.
    Gu D, Zhao Q, Chen J, et al. Reproducibility of blood pressure responses to dietary sodium and potassium interventions: the GenSalt study. Hypertension. 2013;62:499–505. Scholar
  67. 67.
    World Health Organization. Guideline: potassium intake for adults and children. Geneva: WHO; 2012.Google Scholar
  68. 68.
    Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88:987–95. Scholar
  69. 69.
    McDonough AA, Veiras LC, Guevara CA, Ralph DL. Cardiovascular benefits associated with higher dietary K+ vs. lower dietary Na+: evidence from population and mechanistic studies. Am J Physiol Endocrinol Metab. 2017;312:E348–56. Scholar
  70. 70.
    Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004473. Scholar
  71. 71.
    Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100:126–31.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Kelley GA, Kelley KS. Isometric handgrip exercise and resting blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2010;28:411–8. Scholar
  73. 73.
    Patel K, Sui X, Zhang Y, et al. Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. Int J Cardiol. 2013;168:1905–9. Scholar
  74. 74.
    Rahman I, Bellavia A, Wolk A, Orsini N. Physical activity and heart failure risk in a prospective study of men. JACC Heart Fail. 2015;3:681–7. Scholar
  75. 75.
    Pandey A, Garg S, Khunger M, et al. Dose response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation. 2015;132:1786–94. Scholar
  76. 76.
    Ghadieh AS, Saab B. Evidence for exercise training in the management of hypertension in adults. Can Fam Physician. 2015;61:233–9.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: alternative approaches to lowering blood pressure. Hypertension. 2013;61:1360–83.CrossRefGoogle Scholar
  78. 78.
    World Health Organization. Global recommendations on physical activity for health. Geneva: WHO; 2010.Google Scholar
  79. 79.
    Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575–81.CrossRefGoogle Scholar
  80. 80.
    Klatsky AL, Gunderson E. Alcohol and hypertension: a review. J Am Soc Hypertens. 2008;2:307–17.CrossRefGoogle Scholar
  81. 81.
    Thadhani R, Camargo CA, Stampfer MJ, et al. Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch Intern Med. 2002;162:569–74. Scholar
  82. 82.
    Collart F, de Timary P, Dom G, et al. Alcohol-induced hypertension: an important healthcare target in Belgium. Acta Clin Belg. 2015;70:389–95. Scholar
  83. 83.
    Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure. Hypertension. 2001;38:1112–7.CrossRefGoogle Scholar
  84. 84.
    Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e108–20. Scholar
  85. 85.
    Brien SE, Ronksley PE, Turner BJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636. Scholar
  86. 86.
    Mukamal KJ. Understanding the mechanisms that link alcohol and lower risk of coronary heart disease. Clin Chem. 2012;58:664–6.CrossRefGoogle Scholar
  87. 87.
    Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. Scholar
  88. 88.
    Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol. 2010;55:1328–35. Scholar
  89. 89.
    Walsh CR, Larson MG, Evans JC, et al. Alcohol consumption and risk for congestive heart failure in the Framingham heart study. Ann Intern Med. 2002;136:181–91. Scholar
  90. 90.
    Djoussé L, Gaziano JM. Alcohol consumption and heart failure in hypertensive US male physicians. Am J Cardiol. 2008;102:593–7. Scholar
  91. 91.
    Johnson FL. Pathophysiology and etiology of heart failure. Cardiol Clin. 2014;32:9–19.CrossRefGoogle Scholar
  92. 92.
    Laonigro I, Correale M, Di Biase M, Altomare E. Alcohol abuse and heart failure. Eur J Heart Fail. 2009;11:453–62.CrossRefGoogle Scholar
  93. 93.
    Groppelli A, Omboni S, Parati G, Mancia G. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl. 1990;8:S35–40.PubMedGoogle Scholar
  94. 94.
    Grassi G, Seravalle G, Calhoun DA, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90:248–53.CrossRefGoogle Scholar
  95. 95.
    Sørensen K, Kristensen KS, Bang LE, et al. Increased systolic ambulatory blood pressure and microalbuminuria in treated and non-treated hypertensive smokers. Blood Press. 2004;13:362–8. Scholar
  96. 96.
    Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers: a case-control study. JAMA J Am Med Assoc. 1991;265:2226–8. Scholar
  97. 97.
    Bang LE, Buttenschøn L, Kristensen KS, Svendsen TL. Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives. Blood Press Monit. 2000;5:271–4. Scholar
  98. 98.
    Groppelli A, Giorgi DMA, Omboni S, et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens. 1992;10:495–9. Scholar
  99. 99.
    Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ. 1994;309:901. Scholar
  100. 100.
    Patel M, Steinberg M. Smoking cessation. Ann Intern Med. 2016;164:ITC33–48.CrossRefGoogle Scholar
  101. 101.
    Fiore M, Jaen C, Baker T, et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35:158–76. Scholar
  102. 102.
    Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.CrossRefGoogle Scholar
  103. 103.
    Stead L, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5):CD000165.
  104. 104.
    Civljak M, Stead L, Hartmann-Boyce J, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2013;(7):CD007078.
  105. 105.
    Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: cochrane update of 2013 reviews. Addiction. 2014;109:1414–25.CrossRefGoogle Scholar
  106. 106.
    Khoudigian S, Devji T, Lytvyn L, et al. The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis. Int J Public Health. 2016;61:257–67.CrossRefGoogle Scholar
  107. 107.
    Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med (Baltim). 2014;69:248–60. Scholar
  108. 108.
    Rebholz CM, Friedman EE, Powers LJ, et al. Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials. Am J Epidemiol. 2012;176:S27–43. Scholar
  109. 109.
    Tielemans SMAJ, Altorf-van der Kuil W, Engberink MF, et al. Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies. J Hum Hypertens. 2013;27:564–71. Scholar
  110. 110.
    Mente A, Dehghan M, Rangarajan S, et al. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. Lancet Diabetes Endocrinol. 2017;5:774–87. Scholar
  111. 111.
    Whelton SP, Hyre AD, Pedersen B, et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475–81. Scholar
  112. 112.
    Streppel MT, Arends LR, van’t Veer P, et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150–6. Scholar
  113. 113.
    Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5:1417–35. Scholar
  114. 114.
    Yamamoto N, Takano T. Antihypertensive peptides derived from milk proteins. Nahrung. 1999;43:159–64.CrossRefGoogle Scholar
  115. 115.
    Nurminen ML, Sipola M, Kaarto H, et al. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci. 2000;66:1535–43. Scholar
  116. 116.
    Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64:897–903. Scholar
  117. 117.
    Resnick LM. The role of dietary calcium in hypertension: a hierarchal overview. Am J Hypertens. 1999;12:99–112.CrossRefGoogle Scholar
  118. 118.
    van Mierlo LA, Arends LR, Streppel MT, et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens. 2006;20:571–80. Scholar
  119. 119.
    Cormick G, Ciapponi A, Cafferata ML, Belizán JM. Calcium supplementation for prevention of primary hypertension (review). Cochrane Database Syst Rev. 2015;(6):CD010037.
  120. 120.
    Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract. 2008;23:142–51. Scholar
  121. 121.
    Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66:411–8.CrossRefGoogle Scholar
  122. 122.
    Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68:324–33. Scholar
  123. 123.
    Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62:1081–9. Scholar
  124. 124.
    Campbell F, Dickinson HO, Critchley JA, et al. A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol. 2013;20:107–20.CrossRefGoogle Scholar
  125. 125.
    Ried K, Sullivan T, Fakler P, et al. Does chocolate reduce blood pressure? A meta-analysis. BMC Med. 2010;8:39. Scholar
  126. 126.
    Liu G, Mi X-N, Zheng X-X, et al. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2014;112:1043–54. Scholar
  127. 127.
    Steffen M, Kuhle C, Hensrud D, et al. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:2245–54.CrossRefGoogle Scholar
  128. 128.
    Wu L, Sun D, He Y. Fruit and vegetables consumption and incident hypertension: dose–response meta-analysis of prospective cohort studies. J Hum Hypertens. 2016;30:573–80. Scholar
  129. 129.
    Elmer P, Obarzanek E, Vollmer W, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144:485–95.CrossRefGoogle Scholar
  130. 130.
    Group TLAR. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2007;30:1374–83. Scholar
  131. 131.
    The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54. Scholar
  132. 132.
    Pi-Sunyer X. The Look AHEAD trial: a review and discussion of its outcomes. Curr Nutr Rep. 2014;3:387–91. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Diabetes, Nutrition and Metabolic DiseasesUniversity of Medicine and Pharmacy “Iuliu Hatieganu”Cluj-NapocaRomania

Personalised recommendations